Since 1995 we have been supplying topoisomerase products and services to the pharmaceutical industry and academia to aid research in the anti-infectives and anti-cancer markets. Previously trading as John Innes Enterprises, Inspiralis was established upon the research of Professor Tony Maxwell, one of the world's leaders in the field of topoisomerase research.
We are located in laboratories adjacent to the academic research centres of the John Innes Centre and the University of East Anglia on the Norwich Research Park. We maintain close links with the academic research group of Professor Maxwell, helping us to remain at the forefront of the topoisomerase field. The experience of our staff and the connections with the academic group allow us to provide a high level of support to ensure that researchers are able to get the best results using our products. The same scientists who produce our enzymes and substrates also provide the technical support.
Our aim is to provide pharmaceutical companies, and others involved in drug development, with the necessary tools to develop and screen novel anti-infective and anti-cancer compounds. In order to achieve this we will continue to expand the range of topoisomerase products and screening services we offer.